Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SGI-110
SGI-110
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for frontline AML
Endpoints
Tue, 07/31/18 - 10:14 am
Otsuka
SGI-110
clinical trials
AML
Astex Pharmaceuticals shares jump after drug developer announces preliminary study results
Yahoo/AP
Wed, 08/28/13 - 09:10 am
Astex
SGI-110
acute myeloid leukemia
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Astex
AstraZeneca
Celgene
GSK
JNJ
Novartis
SGI-110
Dacogen
Astex Pharmaceuticals provides positive update on SGI-110
Yahoo/Fly on the Wall
Wed, 04/10/13 - 11:07 am
Astex
SGI-110
ovarian cancer
2 Significant Drug Developments Coming Out Of The Biotech Sector
Seeking Alpha
Tue, 12/11/12 - 08:16 am
Astex
SGI-110
Acura Pharmaceuticals
Nexafed
Astex Pharmaceuticals announces positive clinical data for SGI-110
The Fly on the Wall
Tue, 04/3/12 - 08:53 am
SGI-110
Astex
AML
acute myeloid leukemia